Institutions

Combating the opioid crisis requires urgent, evidence-based approaches that address clinical, research, and education issues. Read more:

Don't wait to fill an HRPP position until it's too late. Understand the risks of an understaffed HRPP and how interim staffing support can help. Read more:

The COVID-19 pandemic forced organizations to adjust to continue high-quality research, positioning research to be more patient centric and streamlined.

Advarra is excited to introduce Fireside Chats, a series of virtual conversations. Fireside Chat is an informal conversation between an Advarra representative, and a clinical research thought leader.

Experts answer some of the most popular audience questions from the recent webinar The New Normal: Considerations for Restart Research. Read more:

Panelists from Advarra’s inaugural virtual symposium participated in a Q&A session to address questions submitted by the audience. Read part 1:

Expert panelists from Advarra’s gene therapy virtual symposium address some of the most popular questions submitted by the audience. Read part 2:

With increased efforts to engage and include patient and participant communities more closely in research, when does an IRB review become required?

The global pandemic has changed the way we think about research. Sponsors should consider how the “new normal” will impact sites and current studies.

The pandemic has brought biosafety to the spotlight. This blog discusses guidelines and safety precautions for handling COVID-19 specimens.

Complex trial designs can eliminate less-promising investigational treatments quickly to speed development, but they remain under-utilized. Read more: